Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francesco Juan Manuel DifiledCriticalFrancesco Juan Manuel Di
Priority to ARP010103911priorityCriticalpatent/AR034993A1/en
Publication of AR034993A1publicationCriticalpatent/AR034993A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Comprende entre un 20 y un 40% de bicarbonato de sodio; entre un 15 y 60% de carbonato de calcio; entre un 0,1 y un 30% de carbonato de magnesio; entre un 10 y un 30% de óxido de calcio; entre un 10 y un 25% de óxido de magnesio; entre un 5 y un 25% de aluminosilicatos; y entre un 5 y un 15% de materias insolubles.It comprises between 20 and 40% of sodium bicarbonate; between 15 and 60% calcium carbonate; between 0.1 and 30% magnesium carbonate; between 10 and 30% calcium oxide; between 10 and 25% magnesium oxide; between 5 and 25% aluminosilicates; and between 5 and 15% of insoluble materials.
ARP0101039112001-08-162001-08-16
MEDICINAL PRODUCT FOR THE PREVENTION OF CLINICAL AND SUBCLINICAL ACIDOSIS IN POLICAVITARY AND / OR RUMINANT ANIMALS
AR034993A1
(en)
IMPROVEMENTS INTRODUCED IN THE PURPOSE OF THE MAIN PATENT NUM. 528.972 FOR: PROCEDURE AND INSTALLATION FOR THE CONTINUOUS PRESSURE CRUSHING OF CRACKABLE MATERIAL